Vaccin
July 01, 2020
India’s first COVID-19 vaccine COVAXIN,is granted DCGI approval.
COVAXIN India’s first COVID-19 vaccine,is Granted DCGI approval; human trials are expected to begin in July
- Bharat Biotech has developed the drug.
- Human clinical trials are expected to launch in India in July 2020.
![]() |
| COVAXIN |
The first COVID-19 vaccine candidate in India, COVAXIN, was approved by the DCGI drug regulator for phase I & phase II clinical trials in humans. The drug was developed by Bharat Biotech.
